SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma gets nod to sign JV agreement with Akaal Pharma

15 Feb 2018 Evaluate

Bal Pharma has received an approval for signing the Joint Venture (JV) agreement with Akaal Pharma, Melbourne, Australia for development and marketing of veterinary medicines. ‘AB Vet Pharma’ is being floated in Melbourne , Australia as a joint venture Company (JVC) and Bal Pharma will hold 50% stake in the said JVC. The Board of Directors of the company at its meeting held on February 14, 2018, approved the same.

Bal Pharma is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.

Bal Pharma Share Price

77.19 0.00 (0.00%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1659.55
Dr. Reddys Lab 1218.70
Cipla 1231.35
Zydus Lifesciences 932.55
Lupin 2315.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×